‘Note Pe Chot…’ neither in favour nor against demonetisation: actor Ajay Kkuundal
Mumbai : Actor Ajay Kkuundal says his forthcoming movie titled “Note Pe Chot 8/11”, which is based on demonetisation, is about how it affected the nation and does not favour or criticise Prime Minister Narendra Modi’s decision to withdraw high-denomination notes from circulation.
“It was a decision taken by the government for the benefit of the people. So, the movie doesn’t criticise or favour or is against the decision. The movie talks about how the decision affected the entire nation, which includes people from the middle, upper and lower class,” Ajay said.
“We have tried to show the actual chronological series of the event after demonetisation in a common man’s life,” he added.
Filmmaker Imran Ahmed Khan explores the uncharted territory of the real-life based political-satirical comic genre with “Note Pe Chot At 8/11”.
Talking about his role in the film, Ajay said: “I am playing the role of this serious guy, who is always running away from romance. He is a serious Delhi-based property dealer, who just wants to make money.
“But somehow he meets this girl and decides to get married, and just then demonetisation happens. So the movie is about what happens next in their lives.”
Recent scams, involving billionaire diamond trader Nirav Modi, have shaken the financial system of India. Asked if the movie also highlights the system failure, Ajay said: “See it is a political issue. I don’t know what is happening on that front, but our film is a light-hearted comedy which depicts demonetisation with a touch of laughter. I am sure people would leave the theatre smiling.”
Ajay also admitted that post-demonetisation, he also had to stand in long queues outside banks.
“I have stood in lines, not too many times but two to three times. But this happened to everyone and not just me. In fact, what I am told, some people enjoyed it too,” he said.
The film will hit the screens on March 9.
The experiment began with Hiro Nakauchi, from the University of Tokyo, who grew a mouse with a rat pancreas and a rat with a mouse pancreas.
When cells from the rat-grown mouse pancreas were transplanted into a diabetic mouse, they made enough insulin to cure the condition without being rejected.
Mice and rats are different types of rodents with the former having thin slightly hairy tails, while rats have thicker hairless scaly tails.
“The next step was to move into large animals,” Nakauchi said. Since this was prohibited in Japan, he moved to the Stanford University in the US.
Nakauchi’s rodent work has demonstrated that you can “grow organs in a different species and cure a disease without [suppressing the immune system],” added co-researcher Pablo Ross, Professor at from the University of California, Davis.
“We are working together to translate the technology into humans, to solve the terrible shortage of organs for transplantation. In the US, 20 people die every day because they cannot get the organs they need,” Ross explained.
The novel approach helps to produce animal embryos that are genetically incapable of growing a particular organ.
Then the embryos are injected with human stem cells. The overall proportion of human cells in the chimeric embryo may be small but, as it develops in the womb, the human cells fill the gap and produce the missing organ that the animal’s own genes cannot create, the report said.
If the technology is able to grow human organs inside other species, organ transplants can become a possibility beyond critical conditions.
While it may take many years to develop chimeric transplant technology to the stage where it could be used safely on patient, “things are moving fast,” Ross said.
IANS
